Mumbai: The Food and Drug Administration (FDA) has issued a strict warning to the KEM Hospital blood bank, directing it to maintain adequate stock of fresh whole blood for newborns. The warning follows repeated complaints that the blood bank, run by the Brihanmumbai Municipal Corporation (BMC), has failed to provide such blood, leaving paediatric doctors and parents scrambling to arrange it from other hospitals.

Families Struggle to Secure Blood

In recent months, several families have faced hurdles in obtaining fresh unmodified blood from KEM. Last month, the family of an eight-day-old infant admitted for an exchange transfusion urgently needed fresh “O” positive blood. The KEM blood bank failed to supply it, and the family eventually sourced a unit from Kandivali Shatabdi Hospital.

In

See Full Page